Thetis is a biopharmaceutical company developing first-in-class Resolvin therapies for treatment of cancer and autoimmune diseases. Resolvins are a unique class of endogenous molecules that regulate immune homeostasis.
View Top Employees from Thetis PharmaceuticalsWebsite | http://thetispharma.com/ |
Revenue | $2 million |
Funding | $11.2 million |
Employees | 3 (3 on RocketReach) |
Founded | 2011 |
Address | 54 Danbury Rd Suite 285, Ridgefield, Connecticut 06877, US |
Phone | (203) 936-8936 |
Technologies |
JavaScript,
HTML,
PHP
+9 more
(view full list)
|
Industry | Biotechnology Research, Pharmaceuticals, Clinical Trials, Healthcare, Health Care, Medical, Pharmaceutical |
Web Rank | 20 Million |
Keywords | Thetis Pharmaceuticals |
Competitors | Affymax, Alzprotect, Cerecor, Inc., Inflazyme Pharmaceuticals Ltd., KuDOS Pharmaceuticals |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular Thetis Pharmaceuticals employee's phone or email?
The Thetis Pharmaceuticals annual revenue was $2 million in 2024.
Frank Sciavolino is the Co-Founder, President and Chief Scientific Officer of Thetis Pharmaceuticals.
3 people are employed at Thetis Pharmaceuticals.
Thetis Pharmaceuticals is based in Ridgefield, Connecticut.
The NAICS codes for Thetis Pharmaceuticals are [32541, 3254, 32, 325].
The SIC codes for Thetis Pharmaceuticals are [283, 28].